BIO 2026: Cell and gene therapy sector must break the mold to thrive

If cell and gene therapy makers are going to achieve their mission to improve patients’ lives, the industry must come together to share information across stakeholders, from regulators to manufacturers to payers.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top